ArticleInternational journal of molecular sciences2025
Genotoxicity Assessment of Silver Nanoparticles Produced via HVAD: Examination of Sister Chromatid Exchanges in
Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Silver Nanoparticles as Anticancer Agents: Mechanisms Insight, Current Studies, and Limitations.Pharmaceuticals (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The growing production and use of silver nanoparticles continues to raise questions about their consequences for human and animal health. The method of production, particle stabilization, particle size, concentration, and duration of exposure to cells can affect their reactivity and, consequently, their toxicity. This study was conducted to determine the degree of harmfulness of colloidal silver compounds, including silver nanoparticles produced via the HVAD method, to mitotic chromosomes in chinchilla's cells. Thanks to the sister chromatid exchange (SCE) test, chromosome damage during cell division, i.e., the actual toxic effect of the tested compounds, could be assessed. For this purpose, whole peripheral blood from chinchillas was exposed in vitro to three colloidal silver compounds (unstable AgNP-HVAD, sodium citrate-stabilized silver nanoparticles-[AgNP+C], and silver nitrate) for 3, 6, and 24 h. The toxicity of these compounds was assessed at concentrations of 5, 10, and 20 µg/L and the occurrence of sister chromatid exchanges on chromosomes, resulting from double-strand DNA breaks, was analyzed. The studies revealed a notable increase in SCEs compared to the control group, suggesting the genotoxic properties of the examined AgNPs. The highest level of chromosome damage was observed following exposure to citrate-stabilized silver nanoparticles. Further research is needed to better understand the toxicological mechanisms of AgNPs produced via the HVAD method and their effects on mammalian somatic cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.